- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01243905
Group Psychoeducational Program for Mothers of Children With High Functional Pervasive Developmental Disorders
Group Psychoeducational Program for Mothers of Preschool Children With High Functional Pervasive Developmental Disorders: a Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pervasive Developmental Disorder (PDD) is defined by its unique symptoms such as qualitative impairment in social interaction and communication and restricted repetitive and stereotyped patterns of behavior and interests. Recently, studies have been conducted on PDD without mental retardation, and have reported that the morbidity of PDD is 0.6%-1.7%. Several studies have focused on distress of the mothers of PDD facing atypical development of their children. Some of them have indicated the associations between depression and family history of PDD. Therefore it is important to pay attention to parental mental health.
In Western countries, researchers have investigated the effectiveness of various psychotherapeutic techniques such as childcare counseling and education for mothers about how to treat their children with PDD. It has been reported that one of them which innovates pragmatical methods to manage their children and parental educational programs made improvement in parental adaptation to their children and parental mental health.
However, to the best of our knowledge, few studies have shown the effectiveness of family intervention about PDD in Japan, despite widely implementation of family psychoeducation with various approaches in medical center, public health department. New research may be needed to establish rigorous evidence base for improvement of parental mental health and of behaviors of their children with PDD.
The investigators hypothesized that psychoeducation programs for mothers in addition to treatment as usual to their children would be more effective for parental mental health and behaviors of their children with PDD than treatment usual to their children alone.
The purpose of this study is to examine the effectiveness of psychoeducation to the psychological distress of mothers with the children of high-functioning PDD and to behaviors of the children affected by disorder traits, in a randomized controlled trial.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Aichi
-
Nagoya, Aichi, Japan
- Recruiting
- Nagoya City University Hospital
-
Contact:
- Masako Suzuki, Medical Bachelor
- Email: masako8886@leaf.ocn.ne.jp
-
Principal Investigator:
- Masako Suzuki, MD
-
Nagoya, Aichi, Japan, 467-8601
- Recruiting
- Nagoya City University Hospital
-
Contact:
- Atsurou Yamada, MD, PhD
- Phone Number: 3970 +52-851-5511
- Email: atsurou@med.nagoya-cu.ac.jp
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Mothers whose children have been diagnosed with any disorders by DSM-Ⅳ-TR as: 1) Autistic disorder and not mental retardation; 2) Asperger disorder; or 3) Pervasive developmental disorder not otherwise specified and not mental retardation
- Children were diagnosed at more than 3 months before allocation
- Children were between 2 and 6.5 years and have more than 6 months as pre-school period at allocation
- Mothers who are native speakers of Japanese.
- Mothers who are biological mother of and actually bringing their children.
Exclusion Criteria:
- Mothers who are at risk of taking an emotional toll and unable to understand the contents of psychoeducation for any reason.
- Mothers who are not allowed to participate in this study judged by the doctors of the children for any reason.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Family psychoeducation plus TAU
Family psychoeducational therapy in addition to treatment as usual for the child (TAU)
|
Group psychoeducation every two weeks for eight weeks in addition to treatment as usual administered by physicians
|
|
Placebo Comparator: Treatment as usual
Treatment as usual for the child (TAU)
|
Treatment as usual administered by physicians
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in the total score of the General Health Questionaire 28(GHQ28) at 21 weeks
Time Frame: Baseline, 21 weeks
|
GHQ:It is the shorten version of the General Health Questionaire 60.
It consists four categories;somatic symptoms,anxiety and insomnia,social dysfunction and depressive tendency.
|
Baseline, 21 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in the total score of the General Health Questionaire 28(GHQ28) at 7 weeks
Time Frame: the baseline, 7weeks, 21weeks
|
the baseline, 7weeks, 21weeks
|
|
Change from baseline in the total score of the Abnormal Behavior Checklist at 7 weeks
Time Frame: the baseline, 7weeks, 21weeks
|
the baseline, 7weeks, 21weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Masako Suzuki, MD, Nagoya City University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCUPsychiatry003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pervasive Developmental Disorder
-
Yale UniversityOrganization of Autism Research; Renfield FoundationCompletedPervasive Developmental DisordersUnited States
-
Indiana UniversityUnited States Department of DefenseCompletedAutistic Disorder | Asperger's Disorder | Pervasive Developmental Disorder NOSUnited States
-
Indiana UniversityBristol-Myers Squibb; National Institute of Mental Health (NIMH)CompletedPervasive Developmental DisorderUnited States
-
BeerYaakov Mental Health CenterUnknownPervasive Developmental Disorder
-
Johns Hopkins UniversityForest LaboratoriesTerminatedAutism | Asperger's Disorder | Pervasive Developmental Disorder NOSUnited States
-
Hadassah Medical OrganizationJerusalem Institute for Child DevelopmentUnknownPervasive Developmental DisorderIsrael
-
Milton S. Hershey Medical CenterThrasher Research FundTerminatedAutism | Pervasive Developmental DisorderUnited States
-
Ohio State UniversityAutism SpeaksCompletedAutistic Disorder | Pervasive Developmental DisorderUnited States
-
Massachusetts General HospitalCompletedAutism Spectrum Disorder | ASD | Pervasive Developmental Disorder | PDDUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedChild Development Disorders, PervasiveUnited States
Clinical Trials on Family psychoeducational therapy plus TAU
-
VA Office of Research and DevelopmentCompletedSchizophrenia | Schizoaffective Disorder | Schizophrenia and Related DisordersUnited States
-
University of MiamiNational Institute on Drug Abuse (NIDA)CompletedRisk Behavior | Substance Use Disorders | Psychiatric Disorders | Family DysfunctionUnited States
-
Helse Stavanger HFThe Research Council of NorwayTerminatedDepressive Disorder | Major Depression | Mood DisorderNorway
-
Academisch Medisch Centrum - Universiteit van Amsterdam...KU Leuven; ZonMw: The Netherlands Organisation for Health Research and Development and other collaboratorsRecruiting
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedPTSD | Alcohol Use Disorders | Substance Use DisordersUnited States
-
University of Campania "Luigi Vanvitelli"University of Pisa; University of Bologna; University of Roma La Sapienza; Universita... and other collaboratorsRecruitingDepressive Disorder, MajorItaly
-
University of MiamiNational Institute on Drug Abuse (NIDA)CompletedProblem BehaviorUnited States
-
University of BergenWashington University School of Medicine; Haukeland University HospitalCompleted
-
University of MiamiNational Institute on Drug Abuse (NIDA); Oregon Research InstituteCompletedSubstance AbuseUnited States, Puerto Rico
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedDrug Use DisordersUnited States